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Abstract	  
The detection of extended-spectrum ß-lactamase (ESBL) producers in the fecal flora of 
healthy food-producing animals has increased in recent years. This is mainly attributed to the 
intense use of antibiotics in this sector. There is growing concern regarding the risk of spread 
of such bacteria, especially Escherichia coli and Salmonella, to humans and to the 
environment. The occurrence of ESBL producers in the major groups of livestock, i.e., 
poultry, pigs, cattle and sheep is highlighted and discussed with regard to data that provide 
evidence for transmission of their resistance traits from livestock to humans and to farm 
environments.  
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Introduction 
In human as in veterinary medicine, antimicrobial agents are used therapeutically for the 
treatment of specific conditions of bacterial etiology. Concerning modern livestock industry, 
large amounts of antimicrobial agents are additionally used for prophylactic and 
metaphylactic purposes, as well as for growth promotion. Although antibiotic resistance genes 
occur naturally in many in bacteria, overuse of antimicrobials and inappropriate antibiotic 
stewardship in both human and veterinary sectors have favored the emergence and 
dissemination of antimicrobial resistance (AMR) in bacteria. AMR has now become a public 
health problem of global dimensions. Major health organizations as well as governments 
acknowledge it as one the most significant threats not only to human health, but also to 
agriculture and economic growth [1-3]. In acknowledgement of this dire situation, an 
increasing number of governments have launched national and international strategies for 
tackling AMR, including USA, Canada, Great Britain, Germany  and Australia [4-8]. The 
declared aim is to improve antimicrobial stewardship, monitoring and surveillance, 
international collaboration and, most recently in the case of the USA, reduce the use of 
antibiotics for growth promotion in food animals. 
With regard to AMR, the US Centers for Disease Control and Prevention (CDC) prioritizes 
microorganisms into one of the three categories urgent, serious, and concerning [3]. 
Among the bacteria that are thereby categorized at a serious threat level, CDC lists extended-
spectrum ß-lactamase (ESBL) producing Enterobacteriaceae. ESBL-producing bacteria are of 
particular concern, since they are resistant to many ß-lactam antibiotics including 
cephalosporins of the 3rd and 4th generation such as cefpodoxime, ceftazidime, cefotaxime and 
cefepime, all of which are labeled by the WHO as critically important antimicrobials for 
human medicine [9]. Beyond the use in human medicine, 3rd generation cephalosporins such 
as cefquinome and ceftiofur are important for treating infections in food-producing animals. 
The emergence of ESBL-producing Enterobacteriaceae in livestock and food of animal origin 
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has been documented in recent years and has raised concern regarding the risk of spread to 
humans [10]. 
This review addresses the epidemiology of ESBL-producing bacteria in the human-livestock 
environment and highlights recent studies that offer further insight into the mechanisms of 
putative interspecies transmission routes.  
 
Overview of ESBLs 
ESBLs are bacterial enzymes that hydrolyze the ß-lactam ring of extended-spectrum 
cephalosporins (ceftazidime or cefotaxime) and monobactams (aztreonam) [11]. They 
represent the most important mechanism of antibacterial resistance in Enterobacteriaceae, 
dramatically reducing the efficacy of modern expanded-spectrum cephalosporins (except 
cephamycins and carbapenems). Based on their primary sequence homology [12] and their 
substrate profiles [13], ESBLs can be categorized into classes and groups, respectively, 
whereby the majority of ESBLs belong to Ambler class A and to the Bush group 2be. 
Originally detected in human clinical isolates associated with nosocomial infections in the 
early 1990s, the plasmid-mediated TEM- and SHV-ESBLs were predominant over the 
following decade, but have since been replaced by the globally disseminated CTX-M ß-
lactamases [14-16]. These are cefotaximases that originated from environmental Kluyvera spp 
through mobilization of chromosomal blaCTX-M genes into mobile genetic elements such as 
transposons and plasmids [17]. The CTX-M enzymes are classified according to their amino 
acid similarities into the five major groups CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and 
CTX-M-25 [18]. To date, more than 150 different CTX-M enzymes have been identified and 
registered in the Lahey database (www.lahey.org/studies/). The most prevalent ESBLs belong 
to CTX-M group 1, which includes the enzymes CTX-M-1 and CTX-M-15, and the group 9 
enzyme CTX-M-14 [19]. 
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Plasmids and mobile genetic elements play a key role in the dissemination of blaESBL 
genes 
Plasmids can be defined as double stranded circular DNA units that replicate autonomously 
within the bacterial cell and can be transferred via conjugation to bacteria of the same or of 
different species, promoting horizontal gene transfer [20]. Plasmids are categorized into 
families referred to as incompatibility (Inc) groups (or replicon types), and plasmid multilocus 
sequence types (pMLST), both of which can be determined using PCR methods [20, 21]. 
Different blaESBLs are associated with particular plasmid replicon types. For example, blaCTX-
M-15 is frequently identified on IncFII plasmids, which is a narrow host range plasmid group 
well adapted to proliferate in E. coli, whilst blaCTX-M-1 is predominantly found on plasmids 
belonging to broad host range IncI and IncN groups which are also found in isolates of animal 
origin [18,22]. In addition, many resistance plasmids harbor toxin-antitoxin (TA) factors, 
which are so-called addiction systems that eliminate any post-segregational daughter cells that 
have not inherited the plasmid. This allows for vertical gene transfer and stable maintenance 
of plasmids within the bacterial population, even without selective pressure [23, 24]. 
Addiction systems have been demonstrated for IncF plasmids harboring blaCTX-M-15 [25] and 
for IncI plasmids harboring blaCTX-M-1 [26]. The presence of addiction systems in plasmids 
carrying blaESBL genes and other resistance determinants contribute to epidemiological 
success of ESBL-producing bacteria.  
 
Clones are a further important driving force of the spread of blaESBL genes 
In clinical settings, CTX-M-15 has emerged as one of the most frequent ESBLs associated 
with a pandemic, highly virulent, multidrug resistant E.coli defined by phylogenetic grouping 
[27] and multilocus sequence typing (MLST) [28], as clone E. coli B2:ST131. This clone is 
considered to contribute greatly to the global dissemination of CTXM-15 and is associated 
with hospital as well as community-acquired infections [29, 30]. Other multidrug resistant 
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enterobacterial lineages of clinical importance include virulent extraintestinal clones 
belonging to phylogenetic group D: E. coli D:ST38, E. coli D:ST405 and E. coli D:ST648 are 
all associated with CTX-M-9, CTX-M-14 and CTX-M-15 [31, 32]. 
These and other clones and strains may harbor genes that code for virulence factors (VF) that 
are thought to increase adaptability, competitiveness, and ability to efficiently colonize the 
gastrointestinal tract and contribute to the successful dissemination of the clone [32]. 
 
ESBLs beyond the clinical setting 
Colonization of the gastrointestinal tract is an important factor regarding the epidemiology of 
ESBL-producing Enterobacteriaceae. Recent years have seen a number of studies dedicated to 
screening for ESBL-producing Enterobacteriaceae in the fecal flora of humans in community 
settings, in animals and the environment. Fecal carriage of CTX-M- ESBLs in healthy 
humans is increasing significantly worldwide. A recent analysis of this trend detected vast 
differences between the world regions: In Europe, carriage rates range around or below 10% 
whereas in parts of Southeast Asia and the Eastern Mediterranean over 50% of the population 
is currently found to harbor CTX-M- producing E. coli. In most regions, CTX-M-15 is the 
most prevalent ESBL, and is increasingly replacing CTX-M-14 in Asia, as well as CTX-M-2 
in South America [33]. Other ESBL variants include CTX-M-1 and SHV-12 [34]. The 
increasing prevalence raises questions concerning the risk factors of gut colonization among 
healthy people. Consumption of antimicrobials, hospitalization, premorbidity, African or 
Asian family background and international travel have all have been established as risk 
factors for an individual to become colonized with ESBL-producing bacteria [35-40]. 
Moreover, there is growing concern that resistant E coli originating from food animals may 
present a reservoir of ESBL-producing bacteria and an important threat to human health. 
Several studies have drawn attention to the possibility of the transmission of blaESBL genes, 
their encoding plasmids and the E. coli isolates via fresh food, in particular from poultry meat 
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[41-44]. From such studies it has become evident that CTX-M-1 is currently one of the most 
prevalent ESBL in food-producing animals, at least in poultry. Accordingly, CTX-M-1 
constitutes the most frequently reported ESBL variant in the EU in E. coli originating from 
food-producing animals and foods [45]. It is becoming increasingly clear that livestock 
represents a major reservoir of ESBL-producing E. coli, although the actual impact of this 
reservoir on human health is still insufficiently understood, and linking antibiotic use in food-
producing animals with resistance in human isolates is discussed controversially. Thus, 
understanding epidemiology of extended-spectrum ß-lactamase (ESBL)-producing 
Enterobacteriaceae in the human-livestock environment is important. Recent studies that 
provide further insight into this matter are listed in Table 1 and discussed below. 
 
ESBLs in livestock 
Poultry 
As stated above, poultry represents a major reservoir of CTX-M-1-producing E. coli.  
Zurfluh et al. [46] found that E. coli harboring blaCTX-M-1 on highly similar plasmids 
belonging to group IncI1 and pMLST 3 (IncI1/ST3 plasmids), are persistent at all levels in the 
Swiss broiler production farms, including day-old chicks. From this and other investigations 
in the Netherlands and Germany [47,48], it has become evident that the hatching eggs at the 
tip of the production pyramid play a central role as an entry point of ESBL-producing E. coli 
into broiler farms. In a longitudinal study, Laube and colleagues [48] demonstrated that 
ESBL- producing E. coli increase over time in broilers during the fattening period. It has been 
shown in all studies mentioned above that CTX-M-1-producing E. coli are maintained in 
broiler farms at detection levels between 50% and 100%, even in the absence of antimicrobial 
selective pressure [49]. This high rate of contamination raises questions regarding the risks 
that occupationally involved humans and their environment are exposed to. An investigation 
of Dierikx and collaborators [50] (Table 1) revealed that the prevalence of ESBL-producers in 
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Dutch broiler farmers was 33%, which is much higher compared to the 4.9% described 
previously for the Dutch population [51]. In E. coli isolates from fecal samples from five of 
the six farmers, the combination of detected ESBL genes (blaCTX-M-1 and blaSHV-12) and the 
plasmid group on which the genes were located (IncI1 and IncN, respectively), corresponded 
to genes and plasmids found in isolates from cloacal samples from the broilers. Huijbers et al. 
[52] (Table 1) provided evidence of clonal spread of ESBL-producing E. coli, including 
clones A:ST10(CTX-M-1), A:ST23(CTX-M-1) and extraintestinal pathogenic clone 
D:ST648(SHV-12), between broilers and farm workers and established physical contact with 
live broilers as a risk factor for fecal carriage of ESBL-producers in humans. Carriage rates 
for individuals with close contact to live broilers were found to be 27.1%. For family 
members and employees living on the farm but with no direct contact to live broilers it was 
14.3%, indicating human-to-human transmission. Interestingly, the risk for people living in 
areas around broiler farms was previously found not to be greater than for the general 
population [53]. 
In longitudinal studies investigating the transmission pathways of ESBL-producing E. coli 
from seven German broiler chicken farms and the farms’ environs, Laube et al. [54] (Table 1) 
analyzed samples taken from chicken feces, air and dust inside broiler barns and slurry, air, 
meadows, fields, grass, forest floors and roads surrounding the broiler farms. It was thereby 
demonstrated that ESBL-producing E. coli can be transmitted via the ventilation system to a 
distance of at least 50 m from farms. Other emissions included the application of slurry from 
the broiler farms to fields. On Dutch broiler farms and on laying farms Blaak and 
collaborators [55] (Table 1) found that soil, barn rinse water, flies and fecal samples of farm 
resident pets tested positive for ESBL-producers. With regard to ST, phylogenetic group and 
ESBL-genotype, 60% of these isolates were identical to isolates from poultry feces at the 
same farms. Besides CTX-M-1, the ESBLs SHV-12 and TEM-52 were frequently observed 
(Table 1). These findings are depicted schematically in Fig. 1. Flies circulating throughout 
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broiler farms, mainly Musca domestica, have been implicated as vectors of dissemination of 
ESBL-producers [56] (Table 1). Furthermore, in this study, Solà-Ginés and co-workers  
detected genes encoding virulence factors, predominantly in E. coli A:ST10(CTX-M-1), 
including fimH, astA, iutA, iroN, iss, traT, all of which are genes involved in avian disease as 
well as human extraintestinal infections, such as urinary tract infections [57]. The 
observations from the studies outlined above suggest a considerable risk of diffusion of 
ESBL-producing E. coli clones with possible zoonotic potential from broiler farms. 
 
Pigs 
Frequently observed ESBL variants in E. coli from fecal samples of healthy pigs include 
SHV-12, CTX-M-1-, CTX-M-9 and CTX-M-14 and CTX-M-15. [58,59] (Table 1). Recently, 
pig farms have been identified as reservoirs for TEM-52 [60] (Table 1). TEM-52 was found 
associated to the most part with IncI1/ST3 plasmids and epidemic clone E. coli A:ST10. 
Additionally, CTX-M-1 and CTX-M-32 within IncN/ST1 plasmids and epidemic clone E. 
coli A:ST10 were detected in feces and on hides of pigs, in pig feed and in liquid manure on 
pig farms located throughout Portugal [60].  
Fecal carriage of ESBL-producing Enterobacteriaceae in pigs is a dynamic process, as 
outlined in a longitudinal study by Hansen and collaborators [61] (Table 1). This Danish 
investigation analysed the fecal flora of pigs bred in farrow-to-finish productions systems. In 
such systems, the sows, piglets, weaners and finishers are housed in separated sections on the 
same farm. On all farms, it was shown that fecal carriage of CTX-M-producers was highest in 
the farrowing area and coincided with the use of extended-spectrum penicillins in sows and 
farrows. However, fecal carriage decreased significantly after weaning and was lowest in 
finishers just before slaughter, suggesting that certain practices during the process of 
production influence the status of fecal carriage. One such process was found to be thorough 
cleaning and disinfection of housing sections prior to moving batches of pigs. Thus, although 
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the farrowing area may serve as a reservoir of ESBL-producers, the contamination of 
following batches can be reduced by good sanitation.  
Hammerum and co-workers [62] (Table 1) showed that farm workers with direct contact to 
ESBL-positive pigs had a fecal carriage rate of ESBL-producers of 21%. On four of 20 farms, 
the combination of ESBL genes (mainly CTX-M-1 encoded on IncI1, IncF or IncN plasmids) 
and ESBL-producing E. coli clones, notably E. coli A:ST10(CTX-M-1) and A:ST10(CTX-M-
14), were shared with fecal isolates from the pigs on the same farm (Fig. 1). This strongly 
suggests transmission between pigs and humans. Interestingly, transfer of ESBL-producing 
E. coli from farmers working with pigs to family members not working with pigs was not 
detected. 
Similar to broiler farms, emissions of ESBL producers from pig farms into the environment 
have been reported: An investigation conducted by von Salviati and colleagues [63] (Table 1) 
on seven German pig fattening farms detected identical ESBL-E. coli isolates (with CTX-M-1 
representing the majority) in pig feces, dust, barn air, flies and mouse droppings, and further, 
in slurry and in digestate from biogas plants, both of which were intended for application on 
fields as fertilizers. In addition, fields fertilized one to seven months before sampling tested 
positive for ESBL-producers. Reviewing the results of this systematic study, the authors 
conclude that slurry from pig farms represents a significant emission source for ESBL-
producers. Furthermore, they suggest that biogas plants which apply mesophilic digestion, i.e., 
between 20°C and 40°C, may need to improve treatment conditions to reduce the bacterial 
load in the digestate. 
In pigs, respiratory infections are the main indication for using antimicrobials, followed by 
intestinal diseases in piglets, weaners and fattening pigs and diseases of reproductive organs 
in sows [64]. In a study on the impact of ceftiofur treatment of pigs, Fleury et al. [65] 
observed a dramatic increase of shedding of CTX-M-1 E. coli for three days after injection.  
 11 
Similar results were obtained by Vasseur and colleagues [66], who showed that therapeutic 
doses of cefquinome resulted in a massive amplification of CTX-M-1 producing E. coli in the 
guts of laboratory rats. 
 
Cattle and sheep 
ESBLs in cattle were first observed in fecal samples of cattle and cattle carcasses in Japan in 
2000 [67]. The emergence of CTX-M-2 in cattle was attributed to the use of ceftiofur, which 
was the only expanded-spectrum cephalosporin approved for livestock in Japan at that time. 
Since then, CTX-M-1, CTX-M-13 and CTX-M-14 have been detected sporadically in E. coli 
from cattle in Europe and Asia [10]. In 2010, CTX-M-1 producing E. coli was reported for 
the first time in cattle in the USA [68]. Currently, in Europe, the prevalence of ESBL-
producers in fecal swabs of healthy cattle is 5%-13%, with CTX-M-1 the most prevalent 
variant [69,70]. Since 3rd generation cephalosporins, namely ceftiofur and cefquinome are 
frequently used to treat diseases such as pulmonary infections and mastitis in cattle, the 
question is controversially discussed of whether the therapeutic use of cephalosporins as well 
as the subtherapeutic use of other antimicrobials (i.e., growth promoters/digestive enhancers) 
has contributed to the emergence of ESBLs in cattle and other livestock. Schmid et al, [71] 
found that on German mixed dairy cattle/beef farms, ESBL-producing E. coli strains (mainly 
CTX-M-1-producers) were significantly more often detected in fecal samples from calves 
treated with antimicrobials (ß-lactams as well as others) than in untreated calves. They further 
stated that that calves being fed waste milk (which may contain antibiotic residues) harbored 
more ESBL-producing E. coli. Milk from cows with mastitis may contain CTX-M-1 and 
CTX-M-14 producing Enterobacteriaceae, albeit at a very low rate of 0.4%, as demonstrated 
in an extensive screening study conducted in France by Dahmen and co-workers [72].  
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Cottell and co-workers [73] (Table 1) observed the emergence of CTX-M-32 producing E. 
coli in the fecal samples of 29 of 88 (33%) steers receiving either ceftiofur (14 animals), 
chlortetracycline (4 animals), or both treatments (11 animals). 
A longitudinal study conducted by Hordijk and collaborators [74] (Table 1) showed that veal 
calves collected from different EU countries to be distributed on Dutch fattening farms 
brought with them a high diversity of fecal ESBL-producers, with CTX-M-1, CTX-M-15, 
CTX-M-32 and TEM-52 detected most frequently. On all three fattening farms under 
observation, ESBL diversity declined after prophylactic antimicrobial group treatment, and 
was replaced over a time period of 6 weeks with farm-specific clones: E. coli ST57 harboring 
blaCTX-M-14 on an IncF F2:A-:B- plasmid on one farm, and E. coli ST10 harboring CTX-M-14 
on an IncK plasmid on another. The observations from this study suggest that 
decontaminating pens and other housing facilities prior to arrival of veal calves for fattening 
could help control (re)colonization of calves and the clonal spread of ESBL producers in veal 
calves before slaughter. 
Currently, there is a paucity of data available on the fecal carriage rate and risk factors for 
individuals who have frequent contact with cattle. However, based on the studies on fecal 
carriage of poultry and pig farmers discussed above, it is reasonable to assume that a similar 
occupational hazard exists for cattle farmers. Moreover, pasture soil, manure from cattle and 
amended fields testing positive for ESBL-producing E. coli provide evidence for cattle farms 
as emission sources of ESBL producers [69] (Table 1, Fig. 1). 
Reports on ESBL producers in fecal samples of sheep are rare, but show that to date CTX-M-
14 predominates, at least in Switzerland [70] and the UK [75]. However, a recent study 
conducted by Ramos and collaborators [76] (Table 1) showed that CTX-M-32 is predominant 
in the feces of healthy sheep at slaughter in Portugal. Furthermore, this study revealed that 
ESBL producers isolated from cattle and sheep may contain genes encoding virulence factors 
such as aer and fimA, which are associated with extraintestinal pathogenic E. coli.  
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Together with other studies that analyze ESBL- producing E. coli in pigs and pork [59] and 
poultry and poultry meat [41], these results demonstrate that livestock may represent a 
reservoir of virulence genes as well as blaESBLs. 
 
Pathogenic ESBL producers in livestock 
Although livestock represent a major source of ESBL-producing commensal E. coli, it is 
unclear to what extent blaESBL genes are transferred to zoonotic pathogens. For example, only 
few ESBL-producing enterohaemorrhagic E. coli (EHEC) strains have been reported [77]. 
This is surprising, since cattle are recognized as the main reservoir of EHEC. Nevertheless, 
CTX-M-1 is detected increasingly in other zoonotic pathogens, mostly Salmonella spp, for 
instance in S. Anantum and S. Infantis from cattle and S. Paratyphi B from chicken in 
Germany [78], in S. Llandoff from chicken in France [79], in Salmonella spp. from turkeys 
and from a pig in USA [80], and in Salmonella 4,5,12:i:2- as well as in S. Bovismorbificans 
from pigs in the UK [81]. In all these cases, blaCTX-M-1 was frequently harbored on IncI1 or 
IncN plasmids, which is suggestive of horizontal genetic transfer from commensal E. coli to 
Salmonella within the animal gut. Although currently rare, the prevalence of pathogenic 
CTX-M-1 producers of animal origin involved in human infections must therefore be 
expected to increase in future.  
 
 
Conclusions 
ESBL producers are frequent in the fecal flora of healthy livestock. Certain ESBLS 
(predominantly CTX-M-1, but also CTX-M- 14 and CTX-M-32) are characteristic to 
livestock and their occurrence is frequently linked to specific plasmids (IncI1, IncN) and E. 
coli clones (e.g., A:ST10, A:ST23). Data from recent studies suggest that the therapeutic use 
of expanded-spectrum ß-lactams, in particular ceftiofur in cattle and pigs promotes the 
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emergence and dissemination of CTX-M-1 and CTX-M-32 producing E. coli within farms. 
The studies highlighted in this review provide evidence for the transmission of ESBL-
producing commensal E. coli from livestock to humans occupationally involved in farming 
and to the environment of livestock farms, including air, pathways, slurry, fertilized fields and 
digestate from biogas plants. The impact of ESBL producers of animal origin on human 
health and environmental integrity is just beginning to become apparent. The implementation 
of international and national mitigation strategies including increased surveillance and 
monitoring of AMR as well as the optimization of therapeutic strategies for livestock are 
necessary. On regional and local scales, it is urgent to provide solution-focused approaches. 
These could include improvements in biosecurity and hygiene practices on farms to reduce 
the occupational risk for farmers, and new approaches targeting the safer disposal of 
gastrointestinal waste material (slurry, manure, biogas digestate) in order to limit the 
transmission of ESBL producing E. coli into the environment. 
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Fig. 1 ESBL variants that are found in identical E.coli clones and/or encoded on identical 
plasmids originating from fecal samples of farmers and of livestock, and ESBLs that are 
disseminated from farms to the farm environment via airing systems, gastrointestinal waste, 
or insects 
 
 
 
 
 	  	  	  	  	  	  	  	  
